Biochemical alterations in the retinas of very low-density lipoprotein receptor knockout mice: An animal model of retinal angiomatous proliferation

Archives of Ophthalmology

Volumn 125, Issue 6, 2007, Pages 795-803

  Li, Chao ^a   Huang, Zhong ^a   Kingsley, Ronald ^a   Zhou, Xiaohong ^a   Li, Feng ^a   Parke II, David W ^a   Cao, Wei ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 18; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B BETA; VERY LOW DENSITY LIPOPROTEIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GEL MOBILITY SHIFT ASSAY; GENETIC ANALYSIS; GENETIC IDENTIFICATION; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MOLECULAR DYNAMICS; MOUSE; MUELLER CELL; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RETINA; RETINA ANGIOMATOUS PROLIFERATION; RETINA DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EYE PROTEINS; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-18; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASES; NERVE GROWTH FACTORS; NF-KAPPA B; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, LDL; RETINA; RETINAL NEOVASCULARIZATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERPINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34250312442     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.125.6.795     Document Type: Article

References (52)

1. Yannuzzi LA, Negrao S, Iida T, et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina. 2001;21:416-434.
2. Gross NE, Aizman A, Brucker A, Klancnik JM, Yannuzzi LA. Nature and risk of neovascularization in the fellow eye of patients with unilateral retinal angiomatous proliferation. Retina. 2005;25:713-718.
3. Freund KB, Klais CM, Eandi CM, et al. Sequenced combined intravitreal triamcinolone and indocyanine green angiography-guided photodynamic therapy for retinal angiomatous proliferation. Arch Ophthalmol. 2006;124:487-492.
4. Hartnett ME, Weiter JJ, Staurenghi G, Elsner AE. Deep retinal vascular anomalous complexes in advanced age-related macular degeneration. Ophthalmology. 1996;103:2042-2053.
5. Gass JD, Donald M, Agarwal A, Lavina AM, Tawansy KA. Focal inner retinal hemorrhages in patients with drusen: an early sign of occult choroidal neovascularization and chorioretinal anastomosis. Retina. 2003;23:741-751.
6. Ghazi NG. Retinal angiomatous proliferation in age-related macular degeneration. Retina. 2002;22:509-511.
7. Bottoni F, Massacesi A, Cigada M, Viola F, Musicco I, Staurenghi G. Treatment of retinal angiomatous proliferation in age-related macular degeneration: a series of 104 cases of retinal angiomatous proliferation. Arch Ophthalmol. 2005; 123:1644-1650.
8. Heckenlively JR, Hawes NL, Friedlander M, et al. Model of subretinal neovascularization with choroidal anastomosis. Retina. 2003;23:518-522.
9. Takahashi S, Kawarabayasi Y, Nakai T, Sakai J, Yamamoto T. Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity. Proc Natl Acad Sci U S A. 1992;89:9252-9256.
10. Beisiegel U, Heeren J. Lipoprotein lipase (EC 3.1.1.34) targeting of lipoproteins to receptors. Proc Nutr Soc. 1997;56:731-737.
11. Yagyu H, Lutz EP, Kako Y, et al. Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity: possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency. J Biol Chem. 2002;277:10037-10043.
12. Schlingemann RO. Role of growth factors and the wound healing response in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2004; 242:91-101.
13. Campochiaro PA. Ocular versus extraocular neovascularization: mirror images or vague resemblances. Invest Ophthalmol Vis Sci. 2006;47:462-474.
14. Saint-Geniez M, D'Amore PA. Development and pathology of the hyaloid, choroidal and retinal vasculature. Int J Dev Biol. 2004;48:1045-1058.
15. Cui JZ, Kimura H, Spee C, Thumann G, Hinton DR, Ryan SJ. Natural history of choroidal neovascularization induced by vascular endothelial growth factor in the primate. Graefes Arch Clin Exp Ophthalmol. 2000;238:326-333.
16. Cao W, Tombran-Tink J, Chen W, Mrazek D, Chen W, McGinnis JF. In Vivo protection of photoreceptor cells by pigment epithelium-derived factor (PEDF). Invest Ophthalmol Vis Sci. 2001;42:1646-1652.
17. Yu X, Rajala RVS, McGinnis JF, et al. Involvement of insulin/PI3K/Akt signal pathway in 17 beta-estradiol-mediated neuroprotection. J Biol Chem. 2004;279: 13086-13094.
18. Kong L, Li F, McGinnis JF, et al. Bright cyclic light accelerates photoreceptor cell degeneration in tubby mice. Neurobiol Dis. 2006;21:468-477.
19. Cao W, Chen W, Elias R, McGinnis JF. Recoverin negative photoreceptor cells. J Neurosci Res. 2000;60:195-201.
20. Zhou X, Li F, Kong L, Tomita H, Li C, Cao W. Involvement of inflammation, degradation and apoptosis in a mouse model of glaucoma. J Biol Chem. 2005; 280:31240-31248.
21. Yu X, Tang Y, Li F, et al. Protection against hydrogen peroxide-induced cell death in cultured human retinal pigment epithelial cells by 17β-estradiol: a differential gene expression profile. Mech Ageing Dev. 2005;126:1135-1145.
22. 2) protects human retinal Muller cell against oxidative stress in vitro: evaluation of its effects on gene expression by cDNA microarray. Glia. 2006;53:392-400.
23. Flamme I, von Reutern M, Drexler HC, Syed-Ali S, Risau W. Overexpression of vascular endothelial growth factor in the avian embryo induces hypervascularization and increased vascular permeability without alterations of embryonic pattern formation. Dev Biol. 1995;171:399-414.
24. Adamis AP, Shima DT. The role of vascular endothelial growth factor in ocular health and disease. Retina. 2005;25:111-118.
25. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev. 1992; 13:18-31.
26. Lara N, Aparicio SE, Sawan S, Barnstable CJ, Chang B, Tombran J. Regulation of factors controlling the onset of neovascularization in the VLDLr mutant mouse [ARVO abstract 3155]. Invest Ophthalmol Vis Sci. 2005;46. http://www.arvo.org. Accessed March 23, 2007.
27. Wang W, Hu W, Meng H, Qiao X, Gao H. Expression of angiogenic growth factors in VLDL receptor knockout mouse retina with spontaneous subretinal neovascularization [ARVO abstract 1365]. Invest Ophthalmol Vis Sci. 2005;46. http://www.arvo.org. Accessed March 23, 2007.
28. Hu W, Cao H, Qiao X. Angiogenesis gene profile of the VLDLr mutant mouse with subretinal neovascularization [ARVO abstract 2597]. Invest Ophthalmol Vis Sci. 2006;47. http://www.arvo.org. Accessed March 23, 2007.
29. Basilico C, Moscatelli D. The FGF family of growth factors and oncogenes. Adv Cancer Res. 1992;59:115-165.
30. Consigli SA, Lyser KM, Joseph-Silverstein J. The temporal and spatial expression of basic fibroblast growth factor during ocular development in the chicken. Invest Ophthalmol Vis Sci. 1993;34:559-566.
31. Schulz MW, Chamberlain CG, de Iongh RU, McAvoy JW. Acidic and basic FGF in ocular media and lens: implications for lens polarity and growth patterns. Development. 1993;118:117-126.
32. Bikfalvi A, Klein S, Pintucci G, Rifkin DB. Biological roles of fibroblast growth factor-2. Endocr Rev. 1997;18:26-45.
33. Gómez-Pinilla F, Lee JW, Cotman CW. Basic FGF in adult rat brain: cellular distribution and response to entorhinal lesion and fimbria-formix transection. J Neurosci. 1992;12:345-355.
34. Madigan MC, Penfold PL, Provis JM. Intermediate filament expression in human retinal macroglia: histopathologic changes associated with age-related macular degeneration. Retina. 1994;14:65-74.
35. Shaw G, Weber K. The intermediate filament protein complement of the retina: a comparison between different mammalian species. Eur J Cell Biol. 1984;33: 95-104.
36. Dreher Z, Robinson SR, Distler C. Müller cells in vascular and avascular retinae: a survey of seven mammals. J Comp Neurol. 1992;323:59-80.
37. Bringmann A, Reichenbach A. Role of Muller cells in retinal degenerations. Front Biosci. 2001;6:e72-e92.
38. Gao G, Li Y, Zhang D, Gee S, Crosson C, Ma J. Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization. FEBS Lett. 2001; 489:270-276.
39. Maik-Rachline G, Shaltiel S, Seger R. Extracellular phosphorylation converts pigment epithelium-derived factor from a neurotrophic to an antiangiogenic factor. Blood. 2005;105:670-678.
40. Pearson G, Robinson F, Gibson TB, et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological function. Endocr Rev. 2001;22: 153-183.
41. Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev. 2001; 81:807-869.
42. Kaminska B. MAPK signalling pathways as molecular targets for anti-inflammatory therapy: from molecular mechanisms to therapeutic benefits. Biochim Biophys Acta. 2005;1754:253-262.
43. Abraham E. Akt/protein kinase B. Crit Care Med. 2005;33(suppl):S420-S422.
44. Pollak L, Hanoch T, Rabey MJ, Seger R. Infectious inflammation of the CNS involves activation of mitogen-activated protein kinase and AKT proteins in CSF in humans. Neurol Sci. 2005;26:324-329.
45. Hosokawa Y, Hosokawa I, Ozaki K, Nakae H, Matsuo T. Cytokines differentially regulate ICAM-1 and VCAM-1 expression on human gingival fibroblasts. Clin Exp Immunol. 2006;144:494-502.
46. Chen DY, Lan JL, Lin FJ, Hsieh TY. Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still's disease. Arthritis Rheum. 2005;53:320-327.
47. Mullins RF, Skeie JM, Malone EA, Kuehn MH. Macular and peripheral distribution of ICAM-1 in the human choriocapillaris and retina. Mol Vis. 2006;12: 224-235.
48. Dinarello CA. Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process. Am J Clin Nutr. 2006;83:447S-455S.
49. Burbach GJ, Naik SM, Harten JB, et al. Interleukin-18 expression and modulation in human corneal epithelial cells. Curr Eye Res. 2001;23:64-68.
50. Chandrasekar B, Valente AJ, Freeman GL, Mahimainathan L, Mummidi S. Interleukin-18 induces human cardiac endothelial cell death via a novel signaling pathway involving NF-κB-dependent PTEN activation. Biochem Biophys Res Commun. 2006;339:956-963.
51. Tacken PJ, Teusink B, Jong MC, et al. LDL receptor deficiency unmasks altered VLDL triglyceride metabolism in VLDL receptor transgenic and knockout mice. J Lipid Res. 2000;41:2055-2062.
52. Hembrough TA, Ruiz JF, Papathanassiu AE, Green SJ, Strickland DK. Tissue factor pathway inhibitor inhibits endothelial cell proliferation via association with the very low density lipoprotein receptor. J Biol Chem. 2001;276:12241-12248.